NLRP6: A Multifaceted Innate Immune Sensor

Trends in Immunology

Volumn 38, Issue 4, 2017, Pages 248-260

  Levy, Maayan ^a   Shapiro, Hagit ^a   Thaiss, Christoph A ^a   Elinav, Eran ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

NOD LIKE RECEPTOR PYRIN DOMAIN CONTAINING PROTEIN 6; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; NLRP6 PROTEIN, HUMAN; SIGNAL PEPTIDE;

DYSBIOSIS; GOBLET CELL; HOST MICROBIOME INTERACTION; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION; ANIMAL; IMMUNOLOGY; INFLAMMATION; INTESTINE; INTESTINE FLORA; MAPK SIGNALING; METABOLISM; MICROBIOLOGY; MOUSE;

ANIMALS; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INFLAMMATION; INTESTINES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B;

EID: 85012907304     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2017.01.001     Document Type: Review

References (47)

1. 1 Henao-Mejia, J., et al. Inflammasomes and metabolic disease. Annu. Rev. Physiol. 76 (2014), 57–78.
2. 2 He, W.T., et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res. 25 (2015), 1285–1298.
3. 3 Kayagaki, N., et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526 (2015), 666–671.
4. 4 Liu, X., et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535 (2016), 153–158.
5. 5 Shi, J., et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526 (2015), 660–665.
6. 6 Thaiss, C.A., et al. Integration of innate immune signaling. Trends Immunol. 37 (2016), 84–101.
7. 7 Lupfer, C., Kanneganti, T.D., The expanding role of NLRs in antiviral immunity. Immunol. Rev. 255 (2013), 13–24.
8. 8 Grenier, J.M., et al. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS Lett. 530 (2002), 73–78.
9. 9 Elinav, E., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145 (2011), 745–757.
10. 10 Normand, S., et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 9601–9606.
11. 11 Chen, G.Y., et al. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186 (2011), 7187–7194.
12. 12 Gremel, G., et al. The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling. J. Gastroenterol. 50 (2015), 46–57.
13. 13 Wlodarska, M., et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156 (2014), 1045–1059.
14. 14 Levy, M., et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163 (2015), 1428–1443.
15. 15 Kempster, S.L., et al. Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 300 (2011), G253–G263.
16. 16 Chudnovskiy, A., et al. Host-protozoan interactions protect from mucosal infections through activation of the inflammasome. Cell 167 (2016), 444–456.
17. 17 Sun, Y., et al. Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. Gastroenterology 144 (2013), 1478–1487.
18. 18 Johansson, M.E., et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 15064–15069.
19. 19 Okumura, R., et al. Lypd8 promotes the segregation of flagellated microbiota and colonic epithelia. Nature 532 (2016), 117–121.
20. 20 Vaishnava, S., et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334 (2011), 255–258.
21. 21 Gill, N., et al. Roadblocks in the gut: barriers to enteric infection. Cell Microbiol. 13 (2011), 660–669.
22. 22 Tytgat, K.M., et al. Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology 107 (1994), 1352–1363.
23. 23 Velcich, A., et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295 (2002), 1726–1729.
24. 24 Birchenough, G.M., A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science 352 (2016), 1535–1542.
25. 25 Hooper, L.V., et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4 (2003), 269–273.
26. 26 Salzman, N.H., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11 (2010), 76–83.
27. 27 Huber, S., et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491 (2012), 259–263.
28. 28 Munoz, M., et al. Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity 42 (2015), 321–331.
29. 29 Wang, P., et al. Nlrp6 regulates intestinal antiviral innate immunity. Science 350 (2015), 826–830.
30. 30 Elinav, E., et al. Analysis of microbiota alterations in inflammasome-deficient mice. Methods Mol. Biol. 1040 (2013), 185–194.
31. 31 Palm, N.W., et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158 (2014), 1000–1010.
32. 32 Levy, M., et al. Inflammasomes and the microbiota–partners in the preservation of mucosal homeostasis. Semin. Immunopathol. 37 (2015), 39–46.
33. 33 Hu, B., et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 9862–9867.
34. 34 Henao-Mejia, J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482 (2012), 179–185.
35. 35 Rinella, M.E., Nonalcoholic fatty liver disease: a systematic review. J. Am. Med. Assoc. 313 (2015), 2263–2273.
36. 36 Lee, H.J., et al. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease. World J. Gastroenterol. 21 (2015), 12787–12799.
37. 37 Seregin, S.S., et al. NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury. Mucosal Immunol., 196(1 Suppl), 2016, 126.14.
38. 38 Anand, P.K., et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 488 (2012), 389–393.
39. 39 Mehta, R., et al. Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects. BMC Gastroenterol., 14, 2014, 208.
40. 40 Liu, R., et al. Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components. Oncotarget 6 (2015), 33456–33469.
41. 41 Nasi, M., et al. Analysis of inflammasomes and antiviral sensing components reveals decreased expression of NLRX1 in HIV-positive patients assuming efficient antiretroviral therapy. AIDS 29 (2015), 1937–1941.
42. 42 Gieger, C., et al. New gene functions in megakaryopoiesis and platelet formation. Nature 480 (2011), 201–208.
43. 43 Ydens, E., et al. Nlrp6 promotes recovery after peripheral nerve injury independently of inflammasomes. J. Neuroinflammation, 12, 2015, 143.
44. 44 Albrecht, M., et al. Identification of mammalian orthologs associates PYPAF5 with distinct functional roles. FEBS Lett. 538 (2003), 173–177.
45. 45 Bahar Halpern, K., Nuclear Retention of mRNA in Mammalian Tissues. Cell Rep. 13 (2015), 2653–2662.
46. 46 Stappenbeck, T.S., Virgin, H.W., Accounting for reciprocal host-microbiome interactions in experimental science. Nature 534 (2016), 191–199.
47. 47 Ubeda, C., et al. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J. Exp. Med. 209 (2012), 1445–1456.